Pill imprint MYLAN A4 has been identified as Alprazolam 2 mg.
Alprazolam is used in the treatment of anxiety; depression; panic disorder; tinnitus; dysautonomia and belongs to the drug class benzodiazepines. There is positive evidence of human fetal risk during pregnancy.
Alprazolam 2 mg has a low potential for abuse. The drug has a currently accepted medical use in treatment in the United States. Abuse of the drug may lead to limited physical dependence or psychological dependence relative to the drugs in schedule 3.
Alprazolam
|
|
|
|
|
|
- Inactive Ingredients:
-
- silicon dioxide
- croscarmellose sodium
- docusate sodium
- lactose monohydrate
- magnesium stearate
- microcrystalline cellulose
- sodium benzoate
- sodium lauryl sulfate
- Drug Class:
- Benzodiazepines
- Pregnancy Category:
- D – Positive evidence of risk
- CSA Schedule:
- 4 – Some potential for abuse
- Manufacturer:
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC):
- Pill imprint M 4 has been identified as Hydromorphone hydrochloride 4 mg.
-
Pill imprint Z C 0 2 has been identified as